Code: 05257637

Adenosine and Adenosine Receptors

Name: Adenosine and Adenosine Receptors
Brand: Humana Press Inc.
SKU: 05257637
Price: 240.77 EUR
Availability: InStock

by Michael Williams

Language: English
Binding: Paperback
Number of pages: 516
Publisher: Humana Press Inc., 2011
More about this

240.77 €

Low in stock at our supplier
Shipping in 13 - 16 days

Potřebujete více kusů?Máte-li zájem o více kusů, prověřte, prosím, nejprve dostupnost titulu na naši zákaznické podpoře.

Add to wishlist

Student-Led Conferencing Using Showcase Portfolios
46.95 €
Buy
Contemporary History of Women's Sport, Part One
222.89 €
Buy
ESSENTIAL MUSIC THEORY GRADE 6
63.21 €
Buy
Introduction To The History Of American Diplomacy (1919)
21.60 €
Buy

Give this book as a present today

Order book and choose Gift Order.
We will send you book gift voucher at once. You can give it out to anyone.
Book will be send to donee, nothing more to care about.

Book gift voucher sample Read more

More about Adenosine and Adenosine Receptors

Book details
Synopsis
Trending among others

You get 603 loyalty points

Book synopsis

Historically, the major emphasis on the study of purinergic systems has been predominantly in the areas of physiology and gross pharmacology. The last decade has seen an exponential in crease in the number of publications related to the role of both adenosine and A TP in mammalian tissue function, a level of interest that has evolved from a more molecular focus on the identity of adenosine and A TP receptor subtypes and the search for selective ligands and development of radioligand binding assays by Fred Bruns and colleagues (especially that for A receptors) that played z a highly significant role in advancing research in the area. In the 60 years since adenosine was first shown to be a potent hypotensive agent, a considerable investment has been made by several pharmaceutical companies-including Abbott, Byk Gulden, Takeda, Warner-LambertlParke Davis, Boehringer Mann heim, Boehringer Ingelheim, Nelson/Whitby Research and CffiA Geigy-as well as John Daly's laboratory at the National Institutes of Health, to design new adenosine receptor ligands, and both agon ists and antagonists with the aim of developing new therapeutic entiities. Numerous research tools have derived from these efforts including: 2-chloroadenosine, R-PIA (~-phenylisopropyladeno sine; NECA (5' N-ethylcarboxamidoadenosine); CV1808; CI936; PD 125,944; ~-benzyladenosine; PACPX; CPX; CPT; XAC; CGS 15943 and CGS 21680. Yet in the realm of therapeutics it was only in 1989 that adenosine itself was approved for human use in the treatment of supraventricular arrythmias.